## Abstract For Abstract see ChemInform Abstract in Full Text.
Synthesis of new acylsulfamoyl benzoxaboroles as potent inhibitors of HCV NS3 protease
โ Scribed by Xianfeng Li; Yong-Kang Zhang; Yang Liu; Suoming Zhang; Charles Z. Ding; Yasheen Zhou; Jacob J. Plattner; Stephen J. Baker; Liang Liu; Wei Bu; Wieslaw M. Kazmierski; Lois L. Wright; Gary K. Smith; Richard L. Jarvest; Maosheng Duan; Jing-Jing Ji; Joel P. Cooper; Matthew D. Tallant; Renae M. Crosby; Katrina Creech; Zhi-Jie Ni; Wuxin Zou; Jon Wright
- Book ID
- 104004978
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 668 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0960-894X
No coin nor oath required. For personal study only.
โฆ Synopsis
HCV NS3/4A serine protease is essential for the replication of the HCV virus and has been a clinically validated target. A series of HCV NS3/4A protease inhibitors containing a novel acylsulfamoyl benzoxaborole moiety at the P1' region was synthesized and evaluated. The resulting P1-P3 and P2-P4 macrocyclic inhibitors exhibited sub-nanomolar potency in the enzymatic assay and low nanomolar activity in the cell-based replicon assay. The in vivo PK evaluations of selected compounds are also described.
๐ SIMILAR VOLUMES